Nagapetir represents a novel treatment strategy targeting activated protein C, a crucial element in the blood-forming sequence. This compound functions as a specific enzyme inhibitor, demonstrating hope in diminishing thrombotic events. Preclinical research have revealed favorable outcomes, suggesting that Nagapetir may provide a alternative pos… Read More